DG
Therapeutic Areas
Venturis Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| FGF-based Therapeutic | Diabetic Wounds / Severe Ischemic Heart Disease / Peripheral Artery Disease | Phase 2 |
Leadership Team at Venturis Therapeutics
CA
Calvin A. Wallen III
President, Chairman of the Board
RS
Robert Schleizer
Chief Financial Officer (CFO)